Cost of Clinical Trials: A Breakdown (Infographic)

What are the main costs of clinical trials, and why are they so expensive? Our team at Clinical Research IO searched the literature to find out how clinical trial costs differed by indication, and what the main cost drivers were.

Successful clinical development of a drug, from preclinical testing to marketing approval, requires a vast amount of resources and money. Drug development costs are on the rise, and pharmaceutical/biotechnology companies are seeking solutions for faster and cheaper development. These include repurposing approved drugs for new indications, and incorporating computational biology algorithms into preclinical tests for more efficient screening of molecules, among other methods. Running clinical trials is a major portion of drug development costs. What are the main costs of clinical trials, and why are they so expensive? Our team at Clinical Research IO searched the literature to find out how clinical trial costs differed by indication, and what the main cost drivers were. Check out the clinical trial cost breakdown below.

The evolving landscape of clinical trial software is poised to significantly reduce trial costs, and enable drugs/medical devices to come to market more quickly. If you are considering adopting eSource or CTMS technology for your trials, check out our solutions and request a demo to learn more.

eSource vs EDC – What’s the Difference?

What is eSource? According to the FDA, eSource is defined as “data initially recorded in electronic format. They can include information in original records and certified copies of original records of clinical findings, observations, or other activities captured prior to or during a clinical investigation used for reconstructing and evaluating the investigation.” eSource is already...

Increasing Diversity in Clinical Trials: Dr. Danawi and the Arab Board for Clinical Research

In order to increase diversity in clinical trials, it is important to include voices from many different communities and roles. For this blog post, CRIO employee Stefanie Palmer sat down for a discussion with Dr. Hadi Danawi to talk about involving the Arab American community and people from Middle Eastern backgrounds in clinical research. Who...

Data Management to Data Science – It’s Time!

Over 70% of clinical trial data today comes from non-case report form data. Non-case report form data includes continuous data such as wearable data, lab data, patient reported data and ECG data, to name a few. Generally speaking, these are all collected as source without transcription or entry into another system. Today, we have reached...